TP-122
Sponsors
Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A.
Conditions
Ventilator-Associated Pneumonia
Phase 1
A Randomized, Parallel, Open-Label, Phase 1/2a Study to Assess the Safety and Tolerability of Multiple Doses of the Bacteriophage Cocktail TP-122 (Component TP-122A), for the Treatment of Ventilator-Associated Pneumonia
WithdrawnCTIS2023-508825-29-00
Target: 15Updated: 2024-02-26
A Randomized, Parallel, Open-Label, Phase 1/2a Study to Assess the Safety and Tolerability of Multiple Doses of the Bacteriophage Cocktail TP-122 (Component TP-122A), for the Treatment of Ventilator-Associated Pneumonia
Not yet recruitingCTIS2025-521533-85-00
Target: 30Updated: 2025-09-09